Cargando…
miR-488-5p mitigates hepatic stellate cell activation and hepatic fibrosis via suppressing TET3 expression
BACKGROUND AND AIMS: Numerous studies have demonstrated that hepatic fibrosis, a progressive condition as an endpoint of multiple chronic hepatic diseases, is largely characterized with the extensive activation of hepatic stellate cells (HSCs). The precise effect of miR-488-5p in HSCs during hepatic...
Autores principales: | Qiu, Jiannan, Wu, Shasha, Wang, Peng, Zhou, Yan, Wang, Zhongxia, Sun, Yong, Jiang, Chunping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer India
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10119239/ https://www.ncbi.nlm.nih.gov/pubmed/36001230 http://dx.doi.org/10.1007/s12072-022-10404-w |
Ejemplares similares
-
miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression
por: Wei, Song, et al.
Publicado: (2019) -
miR‐193a/b‐3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells
por: Ju, Baoling, et al.
Publicado: (2019) -
miRNA‐130b‐5p promotes hepatic stellate cell activation and the development of liver fibrosis by suppressing SIRT4 expression
por: Wang, Hao, et al.
Publicado: (2021) -
MiR-34a promotes fibrosis of hepatic stellate cells via the TGF-β pathway
por: Zhang, Jie, et al.
Publicado: (2021) -
miR-185 Inhibits Fibrogenic Activation of Hepatic Stellate Cells and Prevents Liver Fibrosis
por: Zhou, Li, et al.
Publicado: (2017)